Jamie Dananberg, Chief Medical Officer at Unity Biotechnology, Inc. (UBX), sold 3,697 shares at $0.62 ($2K) on 2022-06-21, disclosed to the SEC on 2022-06-22.
Scheduled sale ($2k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANNX | SELL | 2025-02-20 | $16K | — | Filing → |
| UBX | SELL | 2023-04-03 | $714 | — | Filing → |
| UBX | SELL | 2023-03-15 | $4K | — | Filing → |